Cite
HARVARD Citation
Mead, S. et al. (2022). Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme. Lancet neurology. 21 (4), pp. 342-354. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mead, S. et al. (2022). Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme. Lancet neurology. 21 (4), pp. 342-354. [Online].